JZC-01

N/A

Report date: 2023/06/05 17:45:13

Base Information

Drug NameJZC-01

Drug Alias NameJZC-01

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-MICAVascular endothelial growth factor receptor 2 inhibitors

TargetsVascular endothelial growth factor receptor 2MHC class I polypeptide-related sequence A

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesChina Pharmaceutical University

China Registration ClassN/A

Develop Information

Active CompaniesChina Pharmaceutical University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A